Literature DB >> 24994614

Perinatal autopsy evaluation of 2150 autopsies in the Çukurova region of Turkey.

Arbil Açikalin1, Emine Kiliç Bağir, Goncagül Torun, Berna Totan Ateş, Seyda Erdoğan, Aysun Uğuz, Melek Ergın, Selim Büyükkurt, Fatma Tuncay Ozgünen, Nurdan Tunali, Derya Gümürdülü.   

Abstract

OBJECTIVE: We aimed to document the reasons of perinatal deaths in a large autopsy series performed in our institute, which is a reference center in the Çukurova region of Turkey. MATERIAL AND
METHOD: The study included 2150 autopsies performed between January 2000 and December 2012 at our institute. Diagnoses were categorized according to the detected pathologies; congenital malformations were detailed based on systems.
RESULTS: A pathology was detected in 1619 of 2150 (73.3%) autopsies. Congenital malformations were the most common diagnosis with 68.2%. Neural tube defects and central nervous system malformations were the most frequent system malformation in 28.8% of cases, followed by the urogenital system (11.4%) and musculoskeletal system (8.3%), respectively. Malformation syndromes including multisystem anomalies were defined in 109 cases (9.3%).
CONCLUSION: Congenital malformations are the most common reason for perinatal deaths, with autopsy having an additive role to prenatal and genetic evaluations and providing foresight for planning a subsequent pregnancy.

Entities:  

Mesh:

Year:  2014        PMID: 24994614     DOI: 10.5146/tjpath.2014.01266

Source DB:  PubMed          Journal:  Turk Patoloji Derg        ISSN: 1018-5615


  2 in total

Review 1.  Whole-Exome Sequencing and Whole-Genome Sequencing in Critically Ill Neonates Suspected to Have Single-Gene Disorders.

Authors:  Laurie D Smith; Laurel K Willig; Stephen F Kingsmore
Journal:  Cold Spring Harb Perspect Med       Date:  2015-12-18       Impact factor: 6.915

Review 2.  Rapid whole genome sequencing and precision neonatology.

Authors:  Joshua E Petrikin; Laurel K Willig; Laurie D Smith; Stephen F Kingsmore
Journal:  Semin Perinatol       Date:  2015-10-29       Impact factor: 3.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.